Relevant Clinical Trials

COMPLETE Study Results on the Systemic Complement Inhibitor Eculizumab In AMD Patients With Drusen

COMPLETE Study Results on the Systemic Complement Inhibitor Eculizumab In AMD Patients With Drusen

The COMPLETE Study is the first use of systemic complement inhibition for …

Expiration Date: 5/10/2014

Max Credits: 0

View Activity

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

A single intravitreal dose of 125 µg of ocriplasmin achieved resolution of…

Expiration Date: 5/17/2015

Max Credits: 0

View Activity

What Are the Long-Term Effects of Ranibizumab on Diabetic Retinopathy?

What Are the Long-Term Effects of Ranibizumab on Diabetic Retinopathy?

Intravitreal RBZ reduced the risk and rate of DR progression in eyes with …

Expiration Date: 5/17/2015

Max Credits: 0

View Activity

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Early OCT Responses at Day 7 and Month 1 Post Ranibizumab That Predict Vis…

Expiration Date: 8/26/2015

Max Credits: 0

View Activity

Update on Novel Oral Therapy for DME

Update on Novel Oral Therapy for DME

Administered systemically, ASP-440 is a selective, safe and efficacious in…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Does Aspirin Increase Risk of AMD or Disease Progression?

Does Aspirin Increase Risk of AMD or Disease Progression?

The observational AREDS2 results demonstrate an inverse relationship betwe…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Can Fluoconinole Acetonide Implants Manage Uveitis?

Can Fluoconinole Acetonide Implants Manage Uveitis?

In this analysis of the pooled data from the three fluocinolone acetonide …

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

How Safe and Effective is Ranibizumab in AMD after 7 Years?

How Safe and Effective is Ranibizumab in AMD after 7 Years?

This cohort, representing some of the earliest patients treated with intra…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

What Patients at Risk for Geographic Atrophy?

What Patients at Risk for Geographic Atrophy?

We confirm a substantial high risk of developing GA associated with early …

Expiration Date: 6/5/2015

Max Credits: 0

View Activity

Results from the Restore Extension Study of Ranibizumab for DME

Results from the Restore Extension Study of Ranibizumab for DME

The AEs reported in the interim analysis were consistent with the publishe…

Expiration Date: 6/5/2015

Max Credits: 0

View Activity